Hologic’s business focuses on women’s health and well-being. So, it’s no surprise many of its benefits focus on females who want or have kids. The medical devices and products company, with a market ...
StockStory.org on MSN
Hologic (NASDAQ:HOLX) misses Q4 CY2025 revenue estimates
Medical technology company Hologic (NASDAQ:HOLX) in Q4 CY2025 as sales rose 2.5% year on year to $1.05 billion. Its non-GAAP ...
Thought LeadersSarah Smith and Tim SimpsonSenior Marketing Manager and General ManagerHologic In celebration of International Women's Day 2024, we're honored to host Tim Simpson and Sarah Smith from ...
Zacks Investment Research on MSN
HOLX vs. SYK: Which medical device leader is a solid bet now?
The global medical device industry is characterized by rapid technological advances, innovations and scientific discoveries.
HENDERSON, Nev., Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with ...
Company Kicks Off October by Ringing Nasdaq Opening Bell, Releasing Educational Resources for Women MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s ...
BTIG analyst Ryan Zimmerman notes that the U.S. Preventive Services Task Force released a draft recommendation statement on screening for cervical cancer, recommending testing every three years for ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today preliminary revenue results for its first fiscal quarter ended December 30, 2023. The Company expects to report total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results